Search for Clinical Trial Results

Sponsored By

Corynebacterium Infections - 25 Studies Found

Status Study
Active, not recruiting Study Name: Corynebacterium Spp Bone and Joint Infection: Retrospective Study of Microbiological, Diagnostic and Therapeutic Features
Condition: Corynebacterium Infections
Date: 2017-03-09
Not yet recruiting Study Name: Heterologous Effect of Diptheria, Tetanus, Acellular Pertussis Vaccination on Influenza Challenge in the Elderly
Condition: Heterologous Effects of Vaccines
Date: 2016-05-03
Interventions:
  • Biological: Seasonal influenza vaccine

Recruiting Study Name: A Post-marketing, Observational, Retrospective Study to Assess the Safety of RefortrixTM (Tdap) When Administered During Pregnancy in a Maternal Immunization Program in Brazil.
Condition: Diphtheria
Date: 2016-04-28
Interventions: Biological: Combined diphtheria, tetanus and tricomponent acellular pertussis vaccine [Refortrix (Tdap)]
Completed Study Name: Duration of Protection: GSK DTaP Vaccines
Condition:
  • Diphtheria
  • Acellular Pertussis
  • Tetanus

Date: 2015-03-26
Interventions:
  • Biological: Infanrix Diphtheri
Recruiting Study Name: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Pregnant Women
Condition: Diphtheria-Tetanus-acellular Pertussis Vaccines
Date: 2015-02-26
Interventions:
  • Biological: Boostrix™ On
Completed Study Name: Safety of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Healthy Vietnamese Children
Condition:
  • Diphtheria
  • Tetanus
  • Acellular Pertussis

Date: 2013-11-14
Interventions: Biological: Boostrix™ Single-dose administered intramuscularly in the deltoid region of non-domina
Completed Study Name: Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Previously Boosted Young Adults
Condition:
  • Tetanus
  • Acellular Pertussis
  • Diphtheria

Date: 2012-11-21
Interventions: Biological: Boostrix Single dose intramuscular administration.
Completed Study Name: Immunogenicity and Safety Study of Booster Dose of GSK Biologicals' IPV (Poliorix™) and DTPa/Hib (Infanrix+Hib™) Vaccine
Condition:
  • Acellular Pertussis
  • Tetanus
  • Diphtheria
  • Biological: Infanrix+Hib™

Completed Study Name: Immunogenicity and Safety of BoostrixTM Using a New Syringe in 10 to 15-year Old Adolescents
Condition:
  • Diphtheria
  • Tetanus
  • Acellular Pertussis

Date: 2011-05-19
Interventions:
  • Biological: Boostrix TM (new syringe presentation)

Completed Study Name: Immunogenicity and Reactogenicity Study of BoostrixTM (dTpa) and Boostrix-IPV (dTpa-IPV)
Condition:
  • Acellular Pertussis
  • Tetanus
  • Diphtheria

Date: 2011-02-10
Interventions:
  • Biological: Boostrix™ (dTpa)

Next >>>